Genetic Signatures Ltd (GSS) — Capital Reinvestment Ratio
Genetic Signatures Ltd (GSS) has a Capital Reinvestment Ratio of 1.32x as of June 2022, meaning it reinvests 1% of its operating cash flow (AU$1.93 Million) in capital expenditures (AU$2.55 Million). See GSS equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genetic Signatures Ltd Capital Reinvestment Ratio (2021–2022)
This chart tracks Genetic Signatures Ltd's Capital Reinvestment Ratio across 2 annual periods. Check GSS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Genetic Signatures Ltd (2021–2022)
Year-by-year Capital Reinvestment Ratio for Genetic Signatures Ltd from 2021 to 2022. For live market cap and broader valuation context, see GSS company net worth.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.30x | AU$9.81 Million | AU$2.99 Million | ▼ -74.3% |
| 2021 | 1.19x | AU$4.20 Million | AU$4.98 Million | — |